Evidence suggests that MS is mediated by pathogenic CNS-reactive CD4+ T cells and functional deficiencies within the immunosuppressive CD4+ regulatory T cell (Tregs) compartment (3). The gene discussed is CD4; the disease is myeloid sarcoma.